This paper presents the cases of two patients who suffered from panic disorder with agoraphobia and depression. One had been refractory to alprazolam and tricyclics and to behaviour therapy; she had responded to phenelzine, but due to a weight gain of 50 lbs, had discontinued treatment and she relapsed. The second patient, who also suffered from post-traumatic stress disorder, did not respond to alprazolam, imipramine or to phenelzine, but gained weight (33 lbs) on phenelzine. Both patients responded to fluoxetine 80 mg per day without concomitant weight gain.
References
1.
SheehanD.V., BallengerJ., JacobsenG.Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms.Arch Gen Psychiatry1980; 37: 51–59.
WernickeJ.F.The side effect profile and safety of fluoxetine.J Clin Psychiatry1985; 46: 59–67.
4.
ChouinardG.A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.J Clin Psychiatry1985; 46: 32–37.
5.
HamiltonM.A rating scale for depression.J Neurol Neurosurg Psychiatry1961; 23: 56–65.
6.
KleinD.F., GittelmanR., QuitkinF.Diagnosis and drug treatment of psychiatric disorders: adults and children, second edition.Baltimore MD: Williams and Wilkins,1980.
7.
HarrisB., YoungJ., HughesB.Comparative effects of seven antidepressive regimes on appetite, weight and carbohydrate preference.Br J Psychiatry1986; 148: 590–592.
